{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "3158124", "DateCompleted": {"Year": "1985", "Month": "06", "Day": "07"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["ger"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0301-0481", "JournalIssue": {"Volume": "60", "Issue": "3", "PubDate": {"Year": "1985", "Month": "Feb", "Day": "01"}}, "Title": "Zeitschrift fur Hautkrankheiten", "ISOAbbreviation": "Z Hautkr"}, "ArticleTitle": "[Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases].", "Pagination": {"StartPage": "270", "EndPage": "277", "MedlinePgn": "270-7"}, "Abstract": {"AbstractText": ["We report on 161 patients suffering from inflammatory dermatoses on hands, forearms, and lower legs who had been initially treated with 0.1% difluocortolone valerate. During the maintenance therapy carried out over a period of 3 to 4 weeks, we tested the efficacy of Kamillosan cream vs. 0.25% hydrocortisone, 0.75% fluocortin butyl ester, and 5% bufexamac in a bilateral comparative study. For the indications tested Kamillosan cream showed more or less equieffective therapeutic results as compared to 0.25% hydrocortisone. It is superior, however, to the non-steroidal anti-inflammatory agent 5% bufexamac as well as to 0.75% fluocortin butyl ester, a further glucocorticoid. With regard to neurodermitis, Kamillosan cream not only shows the same therapeutic effect as 0.25% hydrocortisone but is even of marked superiority towards other reference products."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Aertgeerts", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Albring", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Klaschka", "ForeName": "F", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nasemann", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Patzelt-Wenczler", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Rauhut", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Weigl", "ForeName": "B", "Initials": "B"}], "PublicationTypeList": ["Clinical Trial", "Comparative Study", "Controlled Clinical Trial", "English Abstract", "Journal Article"], "VernacularTitle": "Vergleichende Pr\u00fcfung von Kamillosan Creme gegen\u00fcber steroidalen (0,25% Hydrocortison, 0,75% Fluocortinbutylester) und nichtsteroidalen (5% Bufexamac) Externa in der Erhaltungstherapie von Ekzemerkrankungen."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Z Hautkr", "NlmUniqueID": "0367576", "ISSNLinking": "0301-0481"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hydroxamic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "0", "NameOfSubstance": "Ointments"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "1A63Z067C8", "NameOfSubstance": "diflucortolone valerate"}, {"RegistryNumber": "4T3C38J78L", "NameOfSubstance": "Bufexamac"}, {"RegistryNumber": "65VXC1MH0J", "NameOfSubstance": "Fluocortolone"}, {"RegistryNumber": "6N7OA9MO7O", "NameOfSubstance": "fluocortin butyl ester"}, {"RegistryNumber": "K253365DXI", "NameOfSubstance": "Diflucortolone"}, {"RegistryNumber": "WI4X0X7BPJ", "NameOfSubstance": "Hydrocortisone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Bufexamac"}, {"QualifierName": [], "DescriptorName": "Chamomile"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Dermatitis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Dermatitis, Contact"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Dermatitis, Seborrheic"}, {"QualifierName": ["administration & dosage", "analogs & derivatives"], "DescriptorName": "Diflucortolone"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "therapeutic use"], "DescriptorName": "Fluocortolone"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Hydrocortisone"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Hydroxamic Acids"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neurodermatitis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": [], "DescriptorName": "Ointments"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1985", "Month": "2", "Day": "1"}, {"Year": "1985", "Month": "2", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1985", "Month": "2", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["3158124"]}}]}